Assembly Biosciences Inc Sustainability Reports
Assembly Biosciences, Inc. is a biotechnology company developing innovative small-molecule therapeutics targeting serious chronic viral diseases. Its pipeline focuses on advancing treatments for herpesvirus, hepatitis B virus (HBV), and hepatitis delta virus (HDV) infections.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5299007Y1X8RBDFT8C40
FIGI: BBG001T9BMW0
4 reports from 2014 to 2024
